- Pharmaceutical companies
- North America
- United States
- Regeneron Pharmaceuticals
Regeneron Pharmaceuticals in United States
Addresses:
-
777 Old Saw Mill River Road, Tarrytown, NY 10591
Web: https://www.regeneron.com
Phone: +1 914-847-7000
-
Sleepy Hollow Office
1 Rockwood Road Sleepy Hollow, NY 10591
Web: https://www.regeneron.com/
Phone: +1 914-847-7000
-
Basking Ridge Office
110 Allen Road Basking Ridge, NJ 07920
Web: https://www.regeneron.com/
Phone: +1 914-847-7000
-
Industrial Operations and Product Supply
81 Columbia Turnpike Rensselaer, NY 12144
Web: https://www.regeneron.com/
Phone: +1 518-488-6000
Other Regeneron Pharmaceuticals's locations around the world
Clinical Trials sponsored by Regeneron Pharmaceuticals
-
Regeneron PharmaceuticalsNog niet aan het werven
-
Regeneron PharmaceuticalsNog niet aan het werven
-
Regeneron PharmaceuticalsWervingRecidiverend/refractair folliculair lymfoom | Marginale zone lymfoom (MZL)Korea, republiek van, Australië, Spanje, Maleisië, Frankrijk, Taiwan, Italië, Polen, Verenigde Staten, Thailand, Verenigd Koninkrijk, Kalkoen, België, Tsjechië
-
Regeneron PharmaceuticalsWerving
-
Regeneron PharmaceuticalsWervingCongenitaal gehoorverlies secundair aan biallele mutaties in het Otoferlin-gen (OTOF) | Biallelische mutaties in het Gap Junction Beta 2 (GJB2) gen | Digene Mutaties in GJB2/Gap Junction Beta 6 (GJB6) genenVerenigde Staten
-
Regeneron PharmaceuticalsNog niet aan het wervenDiabetisch macula-oedeem (DME) | Neovasculaire leeftijdsgebonden maculaire degeneratie (nAMD)
-
Regeneron PharmaceuticalsWervingB-cel non-Hodgkin-lymfoom (B-NHL)Verenigde Staten, Verenigd Koninkrijk
-
Regeneron PharmaceuticalsWerving
-
Regeneron PharmaceuticalsWervingNiet-alcoholische steatohepatitis (NASH) | Metabole disfunctie-geassocieerde steatohepatitis (MASH)Verenigde Staten, Korea, republiek van, Puerto Rico, Japan
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsWervingNiet-kleincellige longkankerDuitsland, Oostenrijk, Frankrijk
About Regeneron Pharmaceuticals
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.